Subsea7 wins FEED contract for Equinor improvement, offshore Norway



Subsea 7 has secured a contract with Equinor for a front-end engineering and design (FEED) research with EPCI1 choice for the Fram Sør improvement venture, offshore Norway.

The research will finalize the technical definition of the proposed subsea improvement previous to Equinor and its companions making the ultimate funding choice. Work will start instantly in our places of work in Norway and UK.

If the EPCI choice is exercised, any ensuing subsea buildings, umbilicals, risers and flowlines (SURF) set up scope could be a direct, substantial2 award to Subsea7. Offshore set up actions related to this contract could be scheduled for 2026, 2027 and 2028.

The Fram Sør space is situated 10-30 kilometers north of the Equinor-operated Troll C platform, roughly 70 kilometers north-west of Bergen. The event might be linked to the prevailing Fram and Troll C infrastructure.

“This award continues our long-standing collaboration with Equinor,” mentioned Erik Femsteinevik, Vice President for Subsea 7 Norway. “The research allows Subsea7 to interact early within the subject improvement course of, optimizing design options and contributing to the ultimate funding choice. We stay up for working carefully with Equinor to unlock the worth in Fram Sør.”

  1. Engineering, procurement, building and set up
  2. Subsea7 defines a considerable contract as being between $150 million and $300 million.





Source link

Related articles

Pump.enjoyable Declares New Upgrades to Creator Charge Mannequin

Pump.enjoyable has acknowledged that there can be adjustments to its creator price mannequin, which triggered a spike within the worth of its native token, PUMP. In keeping with the information by TradingView,...

The Hidden Tradition Dangers Of Fast Progress And How Leaders Can Counter Them

Fast progress — of a staff, division, or firm — is commonly coupled with an underestimation of the cultural...

European inventory markets end the week sturdy

The non-farm payrolls got here in a bit softer than the whisper numbers, giving the "dangerous information is sweet information" crowd a purpose to cheer. For the ECB, it does not change a...

BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Wants, and PROPEL 3 Infigratinib Part 3 Examine Transcript

ObservePlay Earnings NamePlay Earnings Name BridgeBio Pharma, Inc. (BBIO) Discusses Achondroplasia Pathophysiology, Unmet Wants, and PROPEL 3 Infigratinib Part 3 Examine January 9, 2026 8:00 AM EST Firm Contributors Justin ToDaniela...

Anker’s new AeroFit Professional 2 earbuds are already $30 off

We noticed a ton of cool new merchandise at CES 2026, however not all of them made the minimize when it got here to deciding what was better of present. A kind of...
spot_img

Latest articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

WP2Social Auto Publish Powered By : XYZScripts.com